Search

everythinglearnresearchcommunity

for

Search:↓

Deuruxolitinib effectively improves hair regrowth in alopecia areata but requires monitoring for side effects.

A 13-year-old girl with various symptoms was successfully treated for autoimmune disease using the antibiotic co-trimoxazole.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

Upadacitinib successfully regrew hair in a child with alopecia universalis and specific genetic mutations.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

Azathioprine can help with relapses and disability in NMOSD but has more side effects and needs more research.

Ritlecitinib can help about 14,000 people with severe hair loss.

Rapamycin increased survival in mice with severe chronic graft-versus-host disease by expanding regulatory T cells.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

Tofacitinib may be an effective and safe treatment for adolescent alopecia areata.

Managing multiple autoimmune diseases in one patient is very challenging.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

LGD1069 effectively prevents breast tumors in mice without toxicity.

A multi-drug treatment can effectively clear extensive calcinosis in juvenile dermatomyositis.

Medicaid coverage for alopecia areata treatments is inconsistent and often limited.

Propylthiouracil, a thyroid medication, can cause skin blood clots and immune-related blood vessel inflammation.

Co-trimoxazole successfully treated a girl with multiple autoimmune symptoms.

Abrocitinib effectively treats severe alopecia areata with significant improvement and no side effects.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Some medications can improve skin conditions, while lifestyle factors like smoking and drinking may worsen them; treatments like monoclonal antibodies and imiquimod cream show promise for certain skin diseases.

Chrysin makes docetaxel more effective and reduces its side effects in lung cancer treatment.